Skip to main content

Table 4 Multivariate analysis for the association of 68Ga-PSMA-11 PET findings with surgical margin status

From: PSMA-ligand uptake can serve as a novel biomarker in primary prostate cancer to predict outcome after radical prostatectomy

  No. of patients Odds ratio 95% CI p value*
miTNM classification, no., n = 186
 miT status
  2 125 Reference   
  ≥ 3a 61 2.065 0.802–5.315 0.133
 miN status
 No LN metastasis 168 Reference   
 With LN metastasis 18 5.428 1.708–17.249 0.004
 SUVmax of prostatic lesions 183 1.015 0.988–1.044 0.282
 TL of prostatic lesions 183 1.004 0.998–1.011 0.166
  1. CI confidence interval, LN lymph node, PET positron emission tomography, PSMA prostate-specific membrane antigen, SUV standardized uptake value, TL total lesion, TV tumor volume
  2. *Significant associations are given in bold